Check out Russell Brand’s brilliant interview with journalist and broadcaster Jacques Peretti. Jacques Peretti discusses the macro and micro influence of corporate power in our world. Unbelievable stuff, and a great conversation from the two guys.
This is fascinating and essential viewing.
Check it out –
Under The Skin #36 Beyond Conspiracy – The Terrifying Truth Of Corporate Power
“.. Essentially Government has become a kind of a civil service for corporations…”
“…..The U.K. government has announced that former GlaxoSmithKline chief Sir Andrew Witty is to head up its new pathway that aims to get a handful of drugs and medical technologies to patients quicker than ever before.
The plans for the so-called Accelerated Access Review (AAR) will see Sir Andrew, once on the other side of the fence trying to get new drugs onto the market, decide which set of medications and devices can get through to U.K. patients at a much speedier rate.
This also comes two months after he was hired by venture capital firm Hatteras Venture Partners; the firm tells me he will be staying on there, but did not answer questions about any potential conflicts of interest. …”
Who is serving who?
Barely out the door of the pharmaceutical mega-beast of GlaxoSmithKline, and former GSK CEO Andrew Witty was whisked straight into a prime governmental position in the UK. Interestingly, Witty’s new job will entail heading a UK government drug fast-tracking process which is convenient for him considering his old employers -GSK (which he likely holds shares in)- are looking to fast track a new drug at the moment, and will likely need to fast track more in the future.
Does Witty’s connection with GSK concern you? is this a conflict of interest which we should be worried about? Considering GSK’s unethical track record of harming patients, fraud and bribery- should Witty really be bestowed this position of influence in the UK?
Should Witty be in this governmental position?
Remember Witty joined Glaxo in 1985, and worked his way up the ladder there throughout most of his adult life, therefore it would be safe to assume that he has a loyalty to GSK wouldn’t it?
GSK are also currently under investigation with the SFO (Serious Fraud Office) in the UK and the result of that investigation is expected next year. However- chillingly- none of this seems to bother those in the higher echelons of the British state. On the contrary it seems that despite GSK being voted as the worst in the Institute of Director’s ranking for good governance a few weeks ago, and despite GSK consistently in the news for bribe, fraud -and sometimes even corporate manslaughter- scandals (such as with its Paxil/Seroxat drug), the top executives get rewarded regardless.
Imagine being rewarded by the State for working for one of the most despicable corporations on the planet?
How warped is that?
Alongside the bad appointment of Witty, former GSK Executive – Pat Vallance – was also appointed by the UK government into the position of their main scientific advisor. Again, I think we should ask the question :should we be concerned about Pat Vallance’s UK government appointment, particularly given GSK’s unethical track record? And furthermore, if Pat Vallance still holds shares in GSK, does his position create issues around conflicts of interest too?
The press need to start asking these questions, but I won’t hold my breath. The UK press do not confront GSK, if they do it’s rare and they barely scratch the surface most of the time.
For a litany of GSK crimes- which resulted in untold harm to patients and consumers- please read GSK whistle-blower Greg Thorpe’s Department of Justice complaint (see here) from 2012, and remember folks Greg’s complaint led to GSK paying a 3 billion dollar fine for fraud. They were then caught 2 years later operating one the biggest bribery networks ever exposed in China and were fined 500 million there.
This is the tip of the ice-berg folks..